AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Long-Term Investments (2020 - 2025)

AtaiBeckley (ATAI) posted quarterly Long-Term Investments of $42.1 million for Q4 2024.

Analysis

AtaiBeckley (ATAI) Long-Term Investments (2020 - 2025) Analysis & Trends

AtaiBeckley's Long-Term Investments history runs 1 years deep, the most recent figure standing at $42.1 million for Q4 2024.

  • Quarterly Long-Term Investments rose 59.17% year-over-year to $53.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $53.9 million (up 59.17% YoY) and the FY2024 annual result came in at $28.9 million, down 67.84% from the prior year.
  • Long-Term Investments held at $53.9 million in Q3 2025 per ATAI's latest filing, from $53.9 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $89.8 million in Q4 2023 and troughed at $1.5 million in Q3 2021.
  • A 5-year average of $24.8 million and a median of $16.1 million in 2021 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2023 and 2024: Long-Term Investments jumped 1229.76% in 2023, then plunged 67.84% in 2024.
  • Over 5 years, Long-Term Investments stood at $16.1 million in 2021, then slumped by 58.12% to $6.8 million in 2022, then surged by 1229.76% to $89.8 million in 2023, then slumped by 67.84% to $28.9 million in 2024, then surged by 86.75% to $53.9 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $53.9 million, $53.9 million, and $23.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -4.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 372.10 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 AtaiBeckley 1.61 Bn 1.61 Bn - 53.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 53.95 Mn
Jun 30, 2025 53.95 Mn
Mar 31, 2025 42.08 Mn
Dec 31, 2024 42.08 Mn
Dec 31, 2024 42.08 Mn
Sep 30, 2024 45.23 Mn
Jun 30, 2024 61.14 Mn
Mar 31, 2024 90.21 Mn
Dec 31, 2023 89.83 Mn
Sep 30, 2023 71.51 Mn
Jun 30, 2023 3.99 Mn
Mar 31, 2023 5.85 Mn
Dec 31, 2022 6.76 Mn
Sep 30, 2022 8.50 Mn
Jun 30, 2022 9.23 Mn
Mar 31, 2022 10.59 Mn
Dec 31, 2021 16.13 Mn
Sep 30, 2021 15.09 Mn
Jun 30, 2021 19.78 Mn
Dec 31, 2020 8.04 Mn